📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update. (2018)

First Author: Phillips EJ

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1004

PubMed Identifier: 29392710

Publication URI: http://europepmc.org/abstract/MED/29392710

Type: Journal Article/Review

Volume: 103

Parent Publication: Clinical pharmacology and therapeutics

Issue: 4

ISSN: 0009-9236